Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A 2026 systematic review and meta-analysis of randomized controlled trials confirmed that GLP-1 receptor agonists produce clinically meaningful weight loss across diverse patient populations (Ahmad et al., 2026, PMID: 41824845)
Our Identity & Mission Founded by Act of Parliament on 31 August 1992, UNAM is a multicampus, public, research-led institution with a mandate to deliver higher education, advance knowledge through research, provide community extension services, and promote social and economic development in Namibia and beyond
Estimated shortage duration TBD In shortage 6 mg/1 mL In shortage
Semaglutide troche is formulated as a GLP-1 receptor agonist
Furthermore, in obese individuals with sleep disorders, the secretion and activity of GLP-1 RA are decreased, which can lead to abnormal sugar metabolism and weight gain, thereby exacerbating OSA [63, 77, 78]
US$ 25.46
US$ 28.93
US$ 22.23
US$ 24.45
US$ 27.07
US$ 24.02
US$ 28.45
